Management of Respiratory Depression
Immediate Management Steps
- The American Society of Anesthesiologists recommends administering supplemental oxygen to patients with altered level of consciousness, respiratory depression, or hypoxemia 1, 4
- The American Society of Anesthesiologists suggests maintaining intravenous access in all patients with respiratory depression, especially if recurring episodes are anticipated 2, 5
- Administer naloxone for significant opioid-induced respiratory depression regardless of oxygen saturation levels, as clinical presentation is more important than oxygen saturation numbers alone 6
- For adults with opioid-induced respiratory depression, administer naloxone 0.4 mg to 2 mg intravenously, which may be repeated at 2-3 minute intervals if respiratory function does not improve 6
- Consider noninvasive positive-pressure ventilation if frequent or severe airway obstruction or hypoxemia occurs during monitoring 3, 7
Monitoring After Reversal
- Continue supplemental oxygen until the patient is alert with no respiratory depression or hypoxemia 4, 5
- Monitor patients for at least 2 hours after naloxone administration, with longer observation periods for patients on long-acting opioids 6
- Be prepared for possible recurrence of respiratory depression as naloxone's duration of action may be shorter than that of many opioids 6
- Monitor adequacy of ventilation through respiratory rate, depth of respiration, and pattern of breathing 7
- Use continuous pulse oximetry to detect hypoxemia early 7
- Consider end-tidal CO2 monitoring (capnography) which can detect respiratory depression earlier than clinical signs or pulse oximetry alone 7
- Regularly assess alertness and sedation level using a standardized scoring system 7
Prevention Strategies
- Identify patients at increased risk of respiratory depression including those with sleep apnea, obesity, unstable medical conditions, concomitant use of other opioids or sedatives, and extremes of age 5, 8
- Use the lowest efficacious dose of opioids to minimize the risk of respiratory depression 3, 4
- Cautiously administer parenteral opioids or hypnotics in the presence of neuraxial opioids 4, 5
- Increase monitoring intensity and duration for high-risk patients 8
- When clinically suitable, consider single-injection neuraxial fentanyl or sufentanil as safer alternatives to single-injection neuraxial morphine 3, 9
- Continuous epidural opioids are preferred to parenteral opioids for anesthesia and analgesia to reduce the risk of respiratory depression 3, 5